Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes.
暂无分享,去创建一个
J. Contreras | J. Thomas | D. Neville | D. Eckhoff | A. Lobashevsky | F. Thomas | C. Smyth | S. Jenkins | W. Hubbard | S. Stavrou | David M. Neville | Juan L. Contreras | Francis T. Thomas | Judith M. Thomas | William J. Hubbard | Stacie M. Jenkins
[1] J. Contreras,et al. Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques. , 2001, Human immunology.
[2] J. Contreras,et al. CYTOPROTECTION OF PANCREATIC ISLETS BEFORE AND SOON AFTER TRANSPLANTATION BY GENE TRANSFER OF THE ANTI-APOPTOTIC Bcl-2 GENE1 , 2001, Transplantation.
[3] T. Starzl,et al. MUCOSAL DAMAGE AND RECOVERY OF THE INTESTINE AFTER PROLONGED PRESERVATION AND TRANSPLANTATION IN DOGS1 , 2001, Transplantation.
[4] P. Matzinger,et al. Immunity or tolerance: Opposite outcomes of microchimerism from skin grafts , 2001, Nature Medicine.
[5] J. Thomas,et al. Six mamu-A locus alleles defined by a polymerase chain reaction sequence specific primer method. , 2000, Human immunology.
[6] J. Contreras,et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. , 2000, Transplantation.
[7] Fadi G Lakkis,et al. Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue , 2000, Nature Medicine.
[8] B. Hoogwerf,et al. Pancreas transplantation in type 1 diabetes: hope vs reality. , 2000, Cleveland Clinic journal of medicine.
[9] C. Bodian,et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. , 2000, Transplantation.
[10] J. Contreras,et al. Long-term functional islet mass and metabolic function after xenoislet transplantation in primates. , 2000, Transplantation.
[11] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .
[12] Z. Dai,et al. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. , 1999, Current opinion in immunology.
[13] D. Watkins,et al. Identification of DRB alleles in rhesus monkeys using polymerase chain reaction-sequence-specific primers (PCR-SSP) amplification. , 1999, Tissue antigens.
[14] G. Szot,et al. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). , 1999, Transplantation.
[15] J. Contreras,et al. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. , 1999, Surgery.
[16] D. Harlan,et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Harlan,et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. , 1999, Diabetes.
[18] J. Contreras,et al. Reversal of naturally occuring diabetes in primates by unmodified islet xenografts without chronic immunosuppression. , 1999, Transplantation.
[19] W. Cook,et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. , 1999, Transplantation.
[20] M. Zand,et al. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. , 1998, Journal of immunology.
[21] J. Shiloach,et al. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. , 1998, Transplantation.
[22] H. Waldmann,et al. Infectious tolerance. , 1998, Current opinion in immunology.
[23] R. Rajotte,et al. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. , 1997, Journal of immunology.
[24] C. Ricordi,et al. Long-Term Function (6 Years) of Islet Allografts in Type 1 Diabetes , 1997, Diabetes.
[25] G. Szot,et al. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. , 1997, Journal of immunology.
[26] B. Hering,et al. Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts , 1997, Diabetes.
[27] J. Contreras,et al. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. , 1997, Transplantation.
[28] V. Verhasselt,et al. Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor , 1997, European journal of immunology.
[29] P. Nickerson,et al. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? , 1997, Transplantation.
[30] J. Mountz,et al. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation. , 1997, Transplantation proceedings.
[31] S. Bonner-Weir,et al. Beta cell replication and mass in islet transplantation. , 1997, Advances in experimental medicine and biology.
[32] A. Sun,et al. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.
[33] S. Bonner-Weir,et al. Vulnerability of Islets in the Immediate Posttransplantation Period: Dynamic Changes in Structure and Function , 1996, Diabetes.
[34] R. Bontrop,et al. Characterization of the natural immune response of rhesus monkey CD4+ve T cells to the bacterial antigen streptolysin O (SLO) , 1995, Journal of medical primatology.
[35] E. Seaquist,et al. Diminished Insulin Secretory Reserve in Diabetic Pancreas Transplant and Nondiabetic Kidney Transplant Recipients , 1994, Diabetes.
[36] T. Starzl,et al. Hepatic nitric oxide generation as a putative mechanism for failure of intrahepatic islet cell grafts. , 1992, Transplantation proceedings.
[37] S. Bonner-Weir,et al. Correlations of In Vivo β-Cell Function Tests With β-Cell Mass and Pancreatic Insulin Content in Streptozocin-Administered Baboons , 1991, Diabetes.
[38] T. Mosmann,et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.
[39] P. Lacy,et al. Human islet transplantation in patients with type I diabetes. , 1989, Transplantation proceedings.
[40] O. Jonasson,et al. The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantation. , 1985, Annals of surgery.
[41] J. Thomas,et al. SUPPRESSOR CELLS IN RHESUS MONKEYS TREATED WITH ANTITHYMOCYTE GLOBULIN , 1982, Transplantation.
[42] P. Lacy,et al. Transplantation of islets of Langerhans in diabetic rhesus monkeys. , 1975, Surgery.
[43] T. Matsuzawa,et al. The Primates , 1957, Nature.